Please use this identifier to cite or link to this item: http://repositorio.ufc.br/handle/riufc/58965
Type: Artigo de Periódico
Title: Insulin-like plant proteins as potential innovative drugs to treat diabetes—The Moringa oleifera case study
Authors: Paula, Paulo C.
Oliveira, José Tadeu Abreu de
Sousa, Daniele de Oliveira Bezerra de
Alves, Bella Giselly Torres
Carvalho, Ana Fontenele Urano
Franco, Octávio L.
Vasconcelos, Ilka M.
Keywords: Insulin-like plant protein;Hypoglycemic protein;Prospection;Diabetes therapy;Moringa
Issue Date: 2017
Citation: PAULA, P. C. et al. Insulin-like plant proteins as potential innovative drugs to treat diabetes—The Moringa oleifera case study. New Biotechnology, [s.l.], v. 39, p. 99-109, 2017.
Abstract: Various plant species have long been used in traditional medicine worldwide to treat diabetes. Among the plant-based compounds with hypoglycemic properties, studies on insulin-like proteins isolated from leaves, fruits and seeds are rarely reported in the relevant literature. Our research group has been investigating the presence of insulin-like proteins in Moringa oleifera, a plant species native to India, and we have obtained a leaf protein isolate and semi-purified derived fractions, as well as a seed coat protein fraction (Mo-SC), with hypoglycemic activity in chemically induced diabetic mice that have increased tolerance to orally administered glucose. Equally importantly, Mo-SC possesses insulin-like antigenic epitopes. In this context, the present review aims to highlight that prospection of insulin-like proteins in plants is of the utmost importance both for finding new drugs for the treatment of diabetes and for shedding light on the mechanisms involved in diabetes.
URI: http://www.repositorio.ufc.br/handle/riufc/58965
ISSN: 1871-6784
Access Rights: Acesso Aberto
Appears in Collections:DBIO - Artigos publicados em revista científica

Files in This Item:
File Description SizeFormat 
2017_art_pcpaula.pdf1,24 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.